Through a comprehensive analysis encompassing multiple genomic changes within the PI3K pathway, including not only PIK3R1 mutations but also mutations in PIK3CA and PTEN, a more nuanced understanding of the molecular landscape of breast cancer emerges. This evidence concerns the gene PIK3CA and breast carcinoma.